|
FY2026
12 months to Jun 28, 2026
|
FY2025
12 months to Jun 29, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jul 2, 2023
|
FY2022
12 months to Jul 3, 2022
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Reconciliation of net loss to net cash provided by (used in) operating activities, net of acquisitions: | |||||
| Goodwill and intangible impairment | |||||
| Depreciation and amortization | |||||
| Amortization of deferred financing costs | |||||
| Deferred income taxes | |||||
| Bad debt expense | |||||
| Stock-based compensation | |||||
| Other non-cash items | |||||
| Changes in operating items, net of acquisitions: | |||||
| Trade receivables | |||||
| Inventories | |||||
| Prepaid and other | |||||
| Accounts payable and accrued expenses | |||||
| Other assets and other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing activities: | |||||
| Acquisitions, net of cash acquired | |||||
| Capital expenditures | |||||
| Purchase of equity investments | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Acquisition of treasury stock | |||||
| Proceeds from exercise of employee stock options | |||||
| Proceeds from bank borrowings | |||||
| Repayment of bank borrowings | |||||
| Debt issuance costs | |||||
| Net cash used in financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents: | |||||
| Beginning of year | |||||
| End of year |
Loading...